QA: Janux Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001817713_2023_Janux_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001817713, Janux Therapeutics Inc.

  xvar xval
0 AssetsCurrent 332,439,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,086,000
3 remainder_Assets 24,485,000
4 LiabilitiesCurrent 16,507,000
5 LiabilitiesNoncurrent 26,763,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 22,262,000
9 ResearchAndDevelopmentExpense 53,441,000
10 remainder_Expenses 0
11 remainder_Revenues 8,612,000
12 remainder_NetIncome 4,032,000
13 remainder_ComprehensiveNetIncome -1,265,000
  yvar yval
0 Assets 364,010,000
1 Liabilities 43,270,000
2 Expenses 75,703,000
3 Revenues 8,612,000
4 StockholdersEquity 320,740,000
5 NetIncome -63,059,000
6 ComprehensiveNetIncome -63,691,500
7 BaseVar 248,446,000
8 EconomicCapitalRatio 2.40

Edgar->Model Mapping

Feature Distribution

Change over Time